Positive Phase 3 HERIZON-GEA-01 results for Ziihera® (zanidatamab-hrii) in first-line HER2-positive (HER2+) gastroesophageal ...
Deepen your understanding of January 26 through a curated week of First Nations programming and coverage exploring the truth, ...
Educational Development Corporation (NASDAQ: EDUC) Q3 2026 Earnings Call Transcript January 8, 2026 ...